Home › Companies › Globus Medical, Inc. › 2025-2026

Globus Medical, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Globus Medical, Inc.’s Form 8-K, filed 2026-06-04 (Item 5.07 on EDGAR). Page generated 04 October 2026.

9Reported items
581Asset managers
3,318Fund votes
2026-06-03Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Globus Medical, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Globus Medical, Inc.

These tallies are Globus Medical, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-04 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Globus Medical, Inc. — official shareholder meeting results, meeting held 2026-06-03
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Keith W. Pfeil	293,453,432	--	--	28,120,775	6,902,949	Majority: yes
Elect Director: Robert A. Douglas	311,683,904	--	--	9,890,303	6,902,949	Majority: yes
Proposal 2 - Approval of 2021 Equity Incentive Plan Amendment. The Company's stockholders approved the 2021 Equity Incentive Plan Amendment.	246,228,534	75,266,538	79,135	--	6,902,949	Majority: yes
Proposal 3 - Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. The Company's stockholders approved the ratification of the appointm	327,965,803	467,955	43,398	--	0	Majority: yes
Proposal 4 - Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers. The Company's stockholders approved, on a non-binding, advisory basis the 2025 compensation of the Company's named	316,289,675	5,212,943	71,589	--	6,902,949	Majority: yes

Source: Globus Medical, Inc., Form 8-K, filed with the SEC on 2026-06-04 — read the filing on EDGAR.

How asset managers voted at the Globus Medical, Inc. 2025-2026 meeting

Each item below shows how the 581 asset managers that disclosed a Globus Medical, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Globus Medical, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers (the "Say-on-Pay" Vote).

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2026-06-03.

Combines 25 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 316,289,675AGAINST: 5,212,943

Globus Medical, Inc.’s own tally for this item (“Proposal 4 - Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers. The Company's stockholders approved, on a non-binding, advisory basis the 2025 compensation of ”): 316,289,675 for, 5,212,943 against, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 574 asset managers below cast 96% of the shares they voted on this item FOR (110,845,871 for, 4,151,716 against).

FOR 95%

FOR: 110,845,871 (95.5%)AGAINST: 4,151,716 (3.6%)ABSTAIN: 23,383 (0.0%)SPLIT: 1,083,696 (0.9%)NOT VOTED: 7,537 (0.0%)NO VOTE: 197 (0.0%)

Largest asset managers voting on “Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers” at Globus Medical, Inc., 2025-2026
Asset manager	For	Against	Vote
Janus Henderson	14,204,911	24,732	For
Vanguard	11,521,236	14	For
BlackRock	10,056,067	56,084	For
Invesco	7,772,581	225,098	For
JANUS INVESTMENT FUND	4,918,327	0	For
Fidelity	3,430,603	87,655	For
State Street	3,289,240	29,819	For
Charles Schwab	2,483,558	0	For
AllianceBernstein	2,116,735	0	For
JPMorgan	2,115,506	0	For
GEODE CAPITAL MANAGEMENT, LLC	2,105,236	0	For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	1,844,282	0	For
GENEVA CAPITAL MANAGEMENT LLC	1,654,991	0	For
John Hancock	1,470,164	0	For
Sculptor Capital LP	1,388,589	0	For
GW&K Investment Management, LLC	237,062	0	Split
T. Rowe Price	1,159,901	0	For
Dimensional	1,157,819	0	For
Capital Group	1,152,200	0	For
BNP Paribas Asset Management Holding S.A.	0	1,139,872	Against
FULLER & THALER ASSET MANAGEMENT, INC.	1,038,886	0	For
BANK OF MONTREAL /CAN/	963,159	0	For
Citadel	878,545	0	For
Northern Trust	810,374	11,554	For
Artemis Investment Management LLP	787,653	0	For

Showing the 25 largest of 574 asset managers. See all 574 in the interactive database.

2. Approval of an amendment to the Globus Medical, Inc. 2021 Equity Incentive Plan to increase the number of authorized shares thereunder by 1,000,000.

COMPENSATIONMajority of the votes cast: yes

Meeting held 2026-06-03.

Combines 6 wordings of this item as funds reported it.

77% Majority: yes · of votes cast

FOR 77%AGAINST 23%

FOR: 246,228,534AGAINST: 75,266,538

Globus Medical, Inc.’s own tally for this item (“Proposal 2 - Approval of 2021 Equity Incentive Plan Amendment. The Company's stockholders approved the 2021 Equity Incentive Plan Amendment.”): 246,228,534 for, 75,266,538 against, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 142 asset managers below cast 18% of the shares they voted on this item FOR (8,070,134 for, 37,866,563 against).

FOR 18%AGAINST 82%

FOR: 8,070,134 (17.6%)AGAINST: 37,866,563 (82.4%)ABSTAIN: 23,014 (0.1%)NOT VOTED: 133 (0.0%)

Largest asset managers voting on “Approval of an amendment to the Globus Medical, Inc. 2021 Equity Incentive Plan to increase the number of auth” at Globus Medical, Inc., 2025-2026
Asset manager	For	Against	Vote
Vanguard	24,105	10,618,370	Against
BlackRock	0	6,276,333	Against
JANUS INVESTMENT FUND	4,634,482	283,845	For
Invesco	0	4,382,981	Against
Fidelity	0	2,643,467	Against
JPMorgan	2,111,177	0	For
Charles Schwab	880	1,233,473	Against
State Street	21,333	879,797	Against
Capitol Series Trust	0	713,800	Against
Dimensional	0	709,871	Against
AllianceBernstein	0	593,946	Against
Capital Group	0	574,500	Against
Nationwide	0	565,804	Against
Bridge Builder Trust	0	529,171	Against
Equitable	142,412	286,708	Against
T. Rowe Price	0	422,338	Against
BOSTON TRUST WALDEN FUNDS	0	417,462	Against
WILLIAM BLAIR FUNDS	0	396,204	Against
John Hancock	0	388,693	Against
First Trust	0	367,279	Against
OBERWEIS FUNDS	0	347,900	Against
GMO	0	327,787	Against
Jackson National	0	294,108	Against
TOUCHSTONE STRATEGIC TRUST	275,527	0	For
Goldman Sachs	0	264,276	Against

Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.

3. Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the year ending December 31, 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2026-06-03.

Combines 6 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%

FOR: 327,965,803AGAINST: 467,955

Globus Medical, Inc.’s own tally for this item (“Proposal 3 - Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. The Company's stockholders approved the ratifica”): 327,965,803 for, 467,955 against, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 138 asset managers below cast 99.9% of the shares they voted on this item FOR (45,987,640 for, 51 against).

FOR 99.9%

FOR: 45,987,640 (99.9%)AGAINST: 51 (0.0%)ABSTAIN: 23,014 (0.1%)NOT VOTED: 133 (0.0%)

Largest asset managers voting on “Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accoun” at Globus Medical, Inc., 2025-2026
Asset manager	For	Against	Vote
Vanguard	10,642,474	1	For
BlackRock	6,276,333	0	For
JANUS INVESTMENT FUND	4,918,327	0	For
Invesco	4,382,981	0	For
Fidelity	2,643,467	0	For
JPMorgan	2,111,177	0	For
Charles Schwab	1,234,353	0	For
State Street	901,080	50	For
Capitol Series Trust	713,800	0	For
Dimensional	709,871	0	For
AllianceBernstein	593,946	0	For
Capital Group	574,500	0	For
Nationwide	565,804	0	For
Bridge Builder Trust	529,171	0	For
Equitable	429,120	0	For
T. Rowe Price	422,338	0	For
BOSTON TRUST WALDEN FUNDS	417,462	0	For
WILLIAM BLAIR FUNDS	396,204	0	For
John Hancock	388,693	0	For
First Trust	367,279	0	For
OBERWEIS FUNDS	347,900	0	For
GMO	327,787	0	For
Jackson National	294,108	0	For
TOUCHSTONE STRATEGIC TRUST	275,527	0	For
Goldman Sachs	264,276	0	For

Showing the 25 largest of 138 asset managers. See all 138 in the interactive database.

4. Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Keith W. Pfeil

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-06-03.

Combines 5 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%

FOR: 293,453,432WITHHELD: 28,120,775

Globus Medical, Inc.’s own tally for this item (“Elect Director: Keith W. Pfeil”): 293,453,432 for, 28,120,775 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 136 asset managers below cast 100% of the shares they voted on this item FOR (37,502,425 for, 0 against).

FOR 82%ABSTAIN 18%

FOR: 37,502,425 (81.5%)ABSTAIN: 8,489,454 (18.5%)NOT VOTED: 133 (0.0%)

Largest asset managers voting on “Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Keith W. Pfeil” at Globus Medical, Inc., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	10,239,944	402,530	For
BlackRock	6,276,333	0	For
JANUS INVESTMENT FUND	4,634,482	283,845	For
Invesco	4,283,988	98,993	For
Fidelity	2,103,882	539,585	For
JPMorgan	2,111,177	0	For
Charles Schwab	1,234,353	0	For
State Street	900,188	942	For
Capitol Series Trust	0	713,800	Abstain
Dimensional	0	709,871	Abstain
AllianceBernstein	593,946	0	For
Capital Group	574,500	0	For
Nationwide	565,804	0	For
Bridge Builder Trust	24,592	504,579	Abstain
Equitable	429,120	0	For
T. Rowe Price	0	422,338	Abstain
BOSTON TRUST WALDEN FUNDS	0	417,462	Abstain
WILLIAM BLAIR FUNDS	0	396,204	Abstain
John Hancock	0	388,693	Abstain
First Trust	0	367,279	Abstain
OBERWEIS FUNDS	0	347,900	Abstain
GMO	0	327,787	Abstain
Jackson National	277,065	17,043	For
TOUCHSTONE STRATEGIC TRUST	275,527	0	For
Goldman Sachs	264,276	0	For

Showing the 25 largest of 136 asset managers. See all 136 in the interactive database.

5. Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Robert Douglas

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-06-03.

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 311,683,904WITHHELD: 9,890,303

Globus Medical, Inc.’s own tally for this item (“Elect Director: Robert A. Douglas”): 311,683,904 for, 9,890,303 withheld, per its Form 8-K filed 2026-06-04 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Share-of-outstanding not shown: votes cast exceed the reported share count, which usually means multiple share classes with different voting rights.

The 136 asset managers below cast 100% of the shares they voted on this item FOR (42,836,587 for, 0 against).

FOR 93%

FOR: 42,836,587 (93.1%)ABSTAIN: 3,155,294 (6.9%)NOT VOTED: 133 (0.0%)

Largest asset managers voting on “Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Robert Douglas” at Globus Medical, Inc., 2025-2026
Asset manager	For	Abstain	Vote
Vanguard	10,642,443	32	For
BlackRock	6,276,333	0	For
JANUS INVESTMENT FUND	4,918,327	0	For
Invesco	4,382,981	0	For
Fidelity	975,487	1,667,980	Abstain
JPMorgan	2,111,177	0	For
Charles Schwab	1,234,353	0	For
State Street	22,611	878,519	Abstain
Capitol Series Trust	713,800	0	For
Dimensional	709,871	0	For
AllianceBernstein	593,946	0	For
Capital Group	574,500	0	For
Nationwide	565,804	0	For
Bridge Builder Trust	529,171	0	For
Equitable	429,120	0	For
T. Rowe Price	0	422,338	Abstain
BOSTON TRUST WALDEN FUNDS	417,462	0	For
WILLIAM BLAIR FUNDS	396,204	0	For
John Hancock	388,693	0	For
First Trust	367,279	0	For
OBERWEIS FUNDS	347,900	0	For
GMO	327,787	0	For
Jackson National	294,108	0	For
TOUCHSTONE STRATEGIC TRUST	275,527	0	For
Goldman Sachs	264,276	0	For

Showing the 25 largest of 136 asset managers. See all 136 in the interactive database.

6. Amend Omnibus Stock Plan

COMPENSATIONMajority of the votes cast: yes

Meeting held 2026-06-03.

77% Majority: yes · of votes cast

FOR 77%AGAINST 23%

FOR: 246,228,534AGAINST: 75,266,538

The 4 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 342,542 against).

AGAINST 100%

AGAINST: 342,542 (100.0%)

Largest asset managers voting on “Amend Omnibus Stock Plan” at Globus Medical, Inc., 2025-2026
Asset manager	Against	Vote
Varenne Capital Partners	236,783	Against
Empower	91,059	Against
MUTUAL FUND SERIES TRUST	7,500	Against
WASHINGTON CAPITAL MANAGEMENT, INC	7,200	Against

7. Election of Directors (Majority Voting)

DIRECTOR ELECTIONS

Meeting held 2026-06-03.

All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR.

FOR: 100.0%

Largest asset managers voting on “Election of Directors (Majority Voting)” at Globus Medical, Inc., 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
TEALWOOD ASSET MANAGEMENT INC	12,423	0	0	0	For
AMERICAN PENSION INVESTORS TRUST	6,400	0	0	0	For

8. To approve, in an advisory vote, the compensation of the Company's named executive officers (the Say-on-Pay Vote).

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-04 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (149,623 for, 0 against).

FOR: 149,623 (100.0%)

Largest asset managers voting on “To approve, in an advisory vote, the compensation of the Company's named executive officers (the Say-on-Pay Vo” at Globus Medical, Inc., 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
GLENMEDE FUND INC	149,590	0	0	0	For
OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC	33	0	0	0	For

9. To approve, in an advisory vote, the frequency of the approval, on an advisory basis, of the compensation of our named executive officers (the Frequency Vote).

SECTION 14A SAY-ON-PAY VOTES

Meeting held 2025-06-04 (outside the 2025-2026 season's 1 July to 30 June window; reported in this season's filings).

— fund support · no official result

ONE YEAR 99.9%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ONE YEAR: 149,590 (100.0%)3 YEARS: 33 (0.0%)

Largest asset managers voting on “To approve, in an advisory vote, the frequency of the approval, on an advisory basis, of the compensation of o” at Globus Medical, Inc., 2025-2026
Asset manager	For	Against	Abstain	Withheld	Vote
GLENMEDE FUND INC	0	0	0	0	One Year
OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC	0	0	0	0	3 Years

Largest Globus Medical, Inc. shareholders voting in 2025-2026

Ranked by the number of Globus Medical, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 135,744,626 shares outstanding at the time of that meeting.

Top Globus Medical, Inc. shareholders by shares voted, 2025-2026
#	Asset manager	% of shares outstanding
1	Janus Henderson	10.48%
2	Vanguard	8.49%
3	BlackRock	7.45%
4	Invesco	5.89%
5	JANUS INVESTMENT FUND	3.62%
6	Fidelity	2.59%
7	State Street	2.45%
8	Charles Schwab	1.83%
9	AllianceBernstein	1.56%
10	JPMorgan	1.56%

Reported Globus Medical, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Globus Medical, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
Vanguard Group	7.77%	13F
BlackRock	7.73%	13F
Janus Henderson Group plc	5.18%	DEF14A
Invesco	3.18%	13F
State Street	2.64%	13F
JPMorgan Chase	1.91%	13F
Citadel Advisors	1.49%	13F
Dimensional Fund Advisors	1.30%	13F
Charles Schwab	0.92%	13F
David D. Davidar	0.63%	DEF14A

Percentages above are of 135,744,626 shares outstanding, as reported by Globus Medical, Inc. on its Form 10-Q dated 2026-05-05 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Globus Medical, Inc.’s 10-Q dated 2026-05-05. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At Globus Medical, Inc.'s shareholder meeting held 2026-06-03, in the 2025-2026 proxy season, 581 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,318 separate fund positions. Their filings are grouped here into 9 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named… — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Globus Medical, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-04.

Globus Medical, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).